Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patients

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 12, 2009, Pages 1993-1997

  Kahwaji, Joseph ^a   Barker, Eva ^a   Pepkowitz, Sam ^a   Klapper, Ellen ^a   Villicana, Rafael ^a   Peng, Alice ^a   Chang, Robert ^a   Jordan, Stanley C ^a   Vo, Ashley A ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARIMUNE; HUMAN IMMUNOGLOBULIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BLOOD GROUP; CLINICAL ARTICLE; DESENSITIZATION; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG MEGADOSE; FEMALE; HEMOLYTIC ANEMIA; HLA SYSTEM; HUMAN; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; MALE;

ABO BLOOD-GROUP SYSTEM; ACUTE DISEASE; ADULT; AGED; ANEMIA, HEMOLYTIC; AUTOANTIBODIES; CAPRYLATES; FEMALE; GRAFT REJECTION; HEMAGGLUTININS; HLA ANTIGENS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 73649144493     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04540709     Document Type: Article

References (25)

1. Thomas MJ, Misbah SA, Chapel HM, Jones M, Elrington G, Newsom-Davis J: Hemolysis after high-dose intravenous Ig. Blood 82: 3789, 1993
2. Leong H, Stachnik J, Bonk ME, Matuszewski KA: Unlabeled uses of intravenous immune globulin. Am J Health Syst Pharm 65: 1815-1824, 2008
3. El-Shanawany T, Jolles S: Intravenous immunoglobulin and autoimmune disease. Ann N Y Acad Sci 1110: 507-515, 2007
4. El-Shanawany T, Sewell WA, Misbah SA, Jolles S: Current clinical uses of intravenous immunoglobulin. Clin Med 6: 356-359, 2006
5. Waldman M, Kopp J: Parvovirus-B-19-associated complications in renal transplant recipients. Nat Clin Prac Neph 3: 540-550, 2007
6. Sener A, House A, Jevnikar A, Boudville N, McAllister V, Muirhead N, Rehman F, Luke PPW: Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: One-year follow-up of renal allograft recipients. Transplantation 81: 117-120, 2009
7. Pierce LR, Jain N: Risks associated with the use of intravenous immunoglobulin. Transfusion Med Rev 17: 241-251, 2003
8. Vo A, Cam V, Toyoda M, Puliyanda D, Lukovsky M, Bunnapradist S, Peng A, Yang K, Jordan S: Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single center experience. Clin J Am Soc Nephrol 1: 844-852, 2006
9. Jordan SC, Tyan D, Stablein D, McIntosh M, Rose S, Vo A, Toyoda M, Davis C, Shapiro R, Adey D, Milliner D, Graff R, Steiner R, Ciancio G, Sahney S, Light J: Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: Report of the NIH IG02 trial. J Am Soc Nephrol 15: 3256-3262, 2004
10. Brox AG, Cournoyer D, Sternbach M, Spurll G: Hemolytic anemia following intravenous gamma globulin administration. Am J Med 82: 633-635, 1987
11. Daw Z, Padmore R, Neurath D, Cober N, Tokessy M, Desjardins D, Olberg B, Tinmouth A, Giulivi A: Hemolytic transfusion reactions after administraton of intravenous immune (gamma) globulin: A case series analysis. Transfusion 48: 1598-1601, 2008
12. Wilson JR, Bhoopalam H, Fisher M: Hemolytic anemia associated with intravenous immunoglobulin. Muscle Nerve 20: 1142-1145, 1997
13. Coghill J, Comeau T, Shea T, Braddy L, Bandarenko N, Afenyi-Annan A, Harvey D: Acute hemolysis in a patient with cytomegalovirus pneumonitis treated with intravenous immunoglobulin (IVIG). Biol Blood Marrow Transplant 12: 786-788, 2006
14. Comenzo RL, Malachowski ME, Meissner HC, Fulton DR, Berkman EM: Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease. J Pediatr 120: 926-928, 1992
15. Yin F, Nesbitt JA, Tobian AA, Holt PA, Mikdashi J: Hemolytic anemia following intravenous immunoglobulin administration. Am J Hematol 83: 825, 2008
16. Welles CC, Tambra S, Lafayette RA: Hemoglobinuria and acute kidney injury requiring hemodialysis following intravenous immunoglobulin infusion. Am J Kid Dis July 21, 2009 [epub ahead of print]
17. Vo AA, Lukovsky M, Toyoda M, Wang J, Reinsmoen NL, Lai CH, Peng A, Villicana R, Jordan SC: Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med 359: 242-251, 2008
18. Akalin E, Dinavahi R, Friedlander R, Ames S, de Boccardo G, Sehgal V, Schröppel B, Bhaskaran M, Lerner S, Fotino M, Murphy B, Bromberg JS: Addition of plasmapheresis decreases the incidence of acute antibody-mediated rejection in sensitized patients with strong donor-specific antibodies. Clin J Am Soc Nephrol 3: 1160-1167, 2008
19. Hashmi S, Poommipanit N, Kahwaji J, Bunnapradist S: Overview of renal transplantation. Minerva Med 98: 713-729, 2007
20. Shoham-Kessary H, Gershon H: Isoantibodies in immunoglobulin for intravenous use may cause erythrocyte sequestration: Vox Sang 77: 33-39, 1999
21. Shoham-Kessary H, Naot Y, Gershon H: Immune complex-like moieties in immunoglobulin for intravenous use (i.v.Ig) bind complement and enhance phagocytosis of human erythrocytes. Clin Exp Immunol 113: 77-84, 1998
22. Kalantar-Zadeh K: Inflammatory marker mania in chronic kidney disease: Pentraxins at the crossroad of universal soldiers of inflammation. Clin J Am Soc Nephrol 2: 872-875, 2007
23. Silverstein DM: Inflammation in chronic kidney disease: Role in the progression of renal and cardiovascular disease. Pediatr Nephrol 24: 1445-1452, 2008
24. Yilmaz MI, Carrero JJ, Axelsson J, Lindholm B, Stenvinkel P: Low-grade inflammation in chronic kidney disease patients before the start of renal replacement therapy: Sources and consequences. Clin Nephrol 68: 1-9, 2007
25. Mueller-Eckhardt C, Salama A, Mahn I, Kiefel V, Neuzner J, Graubner M: Lack of efficacy of high-dose intravenous immunogloblulin in autoimmune haemolytic anaemia: A clue to its mechanism. Scan J Haematol 34: 394-400, 1985